MedTrace Logo

PREdicting Atrial Fibrillation or Flutter

NCT01851902 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2016-01-05

No results posted yet for this study

Summary

The purpose of this study is to determine, through continuous monitoring with a cardiac monitoring device placed under the skin, the incidence of atrial fibrillation or flutter (AF). The cardiac monitor will be placed in patients without symptoms but at risk for AF. It is hoped that this information may assist health care professionals in treatment decisions related to the early identification of patients at high risk for AF.

Conditions

Sponsors & Collaborators

  • Keesler Air Force Base Medical Center

    lead FED

Principal Investigators

  • Javed M Nasir, MD · Keesler Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01851902 on ClinicalTrials.gov